The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,675.50
Bid: 1,675.00
Ask: 1,675.50
Change: 22.50 (1.36%)
Spread: 0.50 (0.03%)
Open: 1,650.00
High: 1,677.00
Low: 1,646.00
Prev. Close: 1,653.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Health News Summary

Thu, 29th Mar 2018 13:56

Following is a summary of current health news briefs.

Less heart disease, stroke in immigrants than in U.S.-born

People living in the U.S. but born elsewhere may have lowerrisk for heart disease and stroke than their native-bornneighbors, suggests a new study. Foreign-born residents had arange of risks, however. Women from Europe and men from Africaor South America had the lowest stroke rates compared toU.S.-born peers. Heart disease rates were lowest among men andwomen from Asia, the Caribbean, Central America and Mexico andhighest among men from the Indian Subcontinent and Europe.

First women's yoga training center opens doors in Gaza

A small group of Palestinian women in Gaza are stretchingtheir limbs with yoga to help them teach others to cope with thestresses and traumas of living in the embattled territory. TheGaza Strip, which is dominated by the Islamist Hamas faction,has experienced three wars with neighboring Israel in the past11 years.

Happiness 101: Psychology course strikes chord with Yalestudents

The search for life's sweetest but most elusive treasure -happiness - brings nearly 1,200 Yale University undergraduatestwice a week into an enormous hall on the Connecticut school'scampus for its most popular class ever. "Psychology and the GoodLife" is such a hit that one in four undergraduate students atthe Ivy League university is enrolled in the spring semestercourse, said Laurie Santos, the psychology professor who teachesthe class. It is the largest class enrollment size in thehistory of Yale, founded in 1701.

Teva wins reversal of U.S. jury's $235 million GSK drugpatent verdict

A federal judge on Wednesday overturned a U.S. jury'sverdict that required Teva Pharmaceutical Industries Ltdto pay GlaxoSmithKline Plc more than $235million for infringing a patent covering its blood pressure drugCoreg. U.S. District Judge Leonard Stark in Wilmington, Delawareruled that the evidence did not support the jury's finding inJune that Teva sales of a generic version of the drug causeddoctors to infringe GSK's patent.

Childhood cancer survivors may develop heart problems sooner

Adult survivors of childhood cancer have a greater risk ofheart disease and develop risk factors like high blood pressureand elevated cholesterol earlier in life compared to the generalpopulation, a German study suggests. Researchers studied 951adults, ages 23 to 48, who had been diagnosed with cancer whenthey were less than 15 years old. The study team looked at labtests for risk factors for heart disease, and also forconditions like heart failure, stroke and heart attacks. Alongwith the cancer survivors, they studied more than 15,000similar people who didn’t have malignancies as children.

Ireland sets abortion referendum date for May 25

Ireland will hold a referendum on May 25 on whether or notto liberalize its abortion law, the first opportunity in 35years to overhaul one of the world's strictest regimes that haslong divided the once deeply Catholic nation. A complete ban onabortion was only lifted five years ago for cases where themother's life was in danger. That move fueled calls to givevoters under the age of 50 their first say on more comprehensivereform.

Colon cancer screening rates vary widely across U.S.

The proportion of U.S. adults who get recommended coloncancer screenings has never been as high as doctors would like,but a new study suggests that it’s much lower than expected insome pockets of the country. To catch colon cancer early, whenit’s easier to treat and less lethal, physicians typicallyrecommend that adults aged 50 to 75 get screened every 10 yearswith a colonoscopy or annually with fecal tests. Nationwide,only about 67 percent of adults in this age range were currentwith screening, the study found.

FDA working on a 'dozen' policies to boost copycat biotechdrugs

The U.S. Food & Drug Administration is working on around adozen actions to boost use of cheaper versions of expensivebiotech medicines, the head of the agency Scott Gottlieb said onWednesday. The United States has lagged behind Europe in use ofso-called biosimilars, to the frustration of FDA policymakerswho are starting to approve such products but who are seeingother impediments to getting them to consumers.

Listeria class action filed against South Africa's TigerBrands

A class action lawsuit was filed on Thursday against SouthAfrica's Tiger Brands, after one of its food factorieswas linked to a listeria outbreak that has killed 180 peoplesince early 2017, the lawyer running the case said. RichardSpoor, a human rights advocate who previously masterminded amassive class action on behalf of gold miners with silicosis,filed the lawsuit on behalf of families affected by the listeriaoutbreak. The case against Tiger Brands was clear, Spoor said.

Pregnant? Warm weather exercise and hot baths might be okay

Pregnant women who exercise outside on warm days or spend alittle time in a hot bath or sauna may not necessarily raisetheir body temperature enough to cause problems, a researchreview suggests. While most women without health problems cansafely exercise during pregnancy, doctors discourage workouts inhot weather because it can lead to heat stress and dehydration.Physicians also advise women to avoid saunas and hot tubsbecause these activities can raise the body temperature andincrease the risk of birth defects.

More News
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.